Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Arcus Biosciences and WuXi Biologics expand deal for antibodies development

pharmaceutical-technologyDecember 11, 2020

Tag: Arcus Biosciences , Wuxi Biologics , CD39 , antibodies

PharmaSources Customer Service